AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22132950
Drug: Allopurinol (commonly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (commonly prescribed doses)
Trial: 19638331
Drug: L2 spinal
RxNorm normalized name: bovine spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L2 spinal nerve block (n = 30), 1.5 mL of 1% lidocaine
Trial: 19638331
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection (control, n = 30), 1.5 mL of 1% lidocaine
Trial: 1534287
Drug: Intravenous tissue-type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue-type plasminogen activator (t-PA)
Trial: 11188774
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) treatment at a dose of 400 mg/kg bodyweight every 4 weeks
Trial: 9277437
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of nutrients (protein, fat, carbohydrate) at 40, 90, and 160 kcal/h into the duodenum
Trial: 9277437
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of more calories into the duodenum
Trial: 8339523
Drug: 5-Fluorouracil 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-Fluorouracil 1000 mg/m2 and cis-platinum 20 mg/m2 for 5 consecutive days, with retinol palmitate at 15,000 IU b.i.d. in chemotherapy intervals
Trial: 3089050
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% plain (20 ml)
Trial: 3089050
Drug: Diamorphine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diamorphine 2.5 mg in 10 ml normal saline
Trial: 18354383
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor and calcium channel blocker
Trial: 18354383
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor and thiazide diuretic
Trial: 16061709
Drug: Pathogen directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pathogen directed treatment (PDT)
Trial: 16061709
Drug: Empirical broad
RxNorm normalized name: broad leaved paperbark pollen extract
DrugBank: Melaleuca quinquenervia pollen (DB10478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical broad spectrum antibiotic treatment (EAT)
Trial: 11919230
Drug: Chemotherapy regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimens including bolus fluorouracil (5‐FU), 5‐FU and leucovorin, 5‐FU and levamisole, and 5‐FU, leucovorin, and levamisole followed by chemoradiation therapy (pelvic irradiation at 45 Gy with a boost to 50.4 to 54 Gy)
Trial: 10652116
Drug: Sumatriptan 6
RxNorm normalized name: sumatriptan 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 6 mg (Imigran 0.5 mL)
Trial: 8888372
Drug: CDP-choline (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP-choline (single oral dose)
Trial: 6289096
Drug: Cerebral gangliosides
RxNorm normalized name: Sus scrofa cerebral cortex preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebral gangliosides (50 mg once a day) for 40 days
Trial: 18987553
Drug: Pyridostygmine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostygmine (60 mg)
Trial: 18987553
Drug: Bethanechol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bethanechol (25 mg)
Trial: 18987553
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three agents (Pyridostygmine, Buspirone, Bethanechol)
Trial: 16820420
Drug: ChEI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ChEI treatment
Trial: 10102256
Drug: Sibutramine 1
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 1 mg/day
Trial: 8697058
Drug: Sibutramine 5
RxNorm normalized name: sibutramine 5 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 5 mg/day
Trial: 8589555
Drug: Plasmatein (10%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasmatein (10%, v/v; 5 mg/ml)
Trial: 2317144
Drug: Endurance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endurance training program (E) - three times weekly upper and lower conditioning program using target heart rates based on the symptom-limited exercise test (SLXT)
Trial: 2317144
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (C) - continued daily nursing home routine
Trial: 347877
Drug: Bromperidol (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromperidol (4 to 8 mg in one intake in the morning)
Trial: 347877
Drug: Haloperidol (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (4 mg given twice a day)
Trial: 6122939
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml of 5% dextrose in water (D5W) and 1000 ml normal saline (7.5 g dextrose)
Trial: 6122939
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml of D5W, 350 ml of 5% dextrose in normal saline (D5NS), and 650 ml of normal saline (25 g dextrose)
Trial: 6122939
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml D5W and 1000 ml D5NS (57.5 g dextrose)
Trial: 6122939
Drug: 57.5 g
RxNorm normalized name: GENTAMICIN SULFATE 8457.5 g in 8500 g NOT APPLICABLE POWDER [X]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 57.5 g of dextrose
Trial: 17681972
Drug: Liberal fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal fluid administration (median 5050 ml, range 3563-8050 ml)
Trial: 17681972
Drug: Restrictive fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive fluid administration (median 1640 ml, range 935-2250 ml)
Trial: 7667959
Drug: Experimental diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental diet with topinambur (mashed topinambur 100 g/day and cookies with topinambur 50 g/day for 4 weeks)
Trial: 2109195
Drug: Misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (200 micrograms four times daily for 12 weeks)
Trial: 29576354
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (AGE) 3.6 g daily for 6 weeks
Trial: 1710742
Drug: Bezafibrate (Bezalip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (Bezalip Mono, 400 mg daily for 3 months)
Trial: 361149
Drug: Bromocriptine, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine, 5 mg daily
Trial: 26774526
Drug: PRO +
RxNorm normalized name: Climara Pro
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PRO + FAT (micellar casein with 26.7 g milk fat)
Trial: 18300900
Drug: External lumbar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External lumbar drainage (ELD) of cerebrospinal fluid (approximately 135 mL/24 h for 3 days)
Trial: 17136216
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg) and alcohol (1.0 mL 95% USP ethanol/kg body weight)
Trial: 17136216
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and alcohol (1.0 mL 95% USP ethanol/kg body weight)
Trial: 1475230
Drug: Enteric-coated 500-mg
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteric-coated 500-mg naproxen tablets (fasted state)
Trial: 1475230
Drug: Enteric-coated 500-mg
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteric-coated 500-mg naproxen tablets (after breakfast)
Trial: 25358330
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg loading dose of vancomycin
Trial: 25358330
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg traditional dose of vancomycin
Trial: 24617225
Drug: Medicine (dicetel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine (dicetel and bifidobacterium lactobacillus triple viable capsules)
Trial: 21600128
Drug: Propofol 3
RxNorm normalized name: fospropofol 35 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3 µg/ml plus remifentanil 2.5 ng/ml
Trial: 21600128
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 µg/ml plus remifentanil 2.0 ng/ml
Trial: 21600128
Drug: Propofol 4
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 4 µg/ml plus remifentanil 3.0 ng/ml
Trial: 18655554
Drug: Astragalus injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astragalus injection (40 mL, 10 mL containing 2 g of crude drug)
Trial: 18655554
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Astragalus injection)
Trial: 17068655
Drug: IntraSite Gel
RxNorm normalized name: Intrasite Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IntraSite Gel
Trial: 10918470
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (4 glasses, 40 g alcohol/day)
Trial: 10918470
Drug: Beer (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beer (4 glasses, 40 g alcohol/day)
Trial: 10918470
Drug: Spirits (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirits (4 glasses, 40 g alcohol/day)
Trial: 8157948
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy with enalapril (20-40 mg once a day)
Trial: 8157948
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy with enalapril
Trial: 3145964
Drug: combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combination of alpha-interferon and gamma-interferon
Trial: 24977689
Drug: Oral stimulation
RxNorm normalized name: follicle stimulating hormone / luteinizing hormone Injection [Menopur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral stimulation (OS)
Trial: 31489639
Drug: Talazoparib 1
RxNorm normalized name: talazoparib 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talazoparib 1 mg capsule
Trial: 31489639
Drug: Talazoparib 0.75
RxNorm normalized name: talazoparib 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talazoparib 0.75 mg daily dose
Trial: 20512414
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg entecavir daily until October 2009 (group A)
Trial: 20512414
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg lamivudine daily until October 2009 (group B)
Trial: 16078322
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy > 10 mg prednisolone equivalent per day
Trial: 10636369
Drug: Third-generation oral
RxNorm normalized name: celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Third-generation oral contraceptive (150 microg desogestrel and 30 microg ethinyloestradiol)
Trial: 10636369
Drug: Second-generation oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second-generation oral contraceptive (150 microg levonorgestrel and 30 microg ethinyloestradiol)
Trial: 3873108
Drug: co‐trimoxazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: co‐trimoxazole (800 mg sulphamethoxazole + 160 mg trimethoprim)
Trial: 3873108
Drug: trimethoprim (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trimethoprim (200 mg)
Trial: 31204264
Drug: Low-Intensity Shockwave
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Intensity Shockwave Therapy (LiST)
Trial: 27063317
Drug: Suggestion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suggestion therapy
Trial: 15704046
Drug: Etidronate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etidronate (400 mg orally for 14 days) plus calcium (500 mg daily) and vitamin D (400 IU daily) for 76 days, repeated 8 times over 24 months
Trial: 15704046
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg daily) and vitamin D (400 IU daily) for 76 days, repeated 8 times over 24 months without etidronate
Trial: 12081675
Drug: 100 U
RxNorm normalized name: vitamin E 100 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 U BTX‐A (50 U/ml/axilla)
Trial: 8648964
Drug: Small dose
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dose kaliposol + etomidate
Trial: 8263318
Drug: Sertraline (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (mean daily dose 72 mg)
Trial: 8263318
Drug: Fluoxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (mean daily dose 28 mg)
Trial: 4072939
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 or 100 mg/day)
Trial: 4072939
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Diltiazem and Hydrochlorothiazide
Trial: 30843453
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg THA
Trial: 30843453
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg THA
Trial: 29465273
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) antipsychotic delivery
Trial: 22755270
Drug: 0.8 ml
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 ml of 4 mg 0.5% hyperbaric bupivacaine
Trial: 22755270
Drug: 1.3-ml solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3-ml solution of 4 mg 0.5% hyperbaric bupivacaine + 25 microg of fentanyl
Trial: 22755270
Drug: 1.1-ml solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.1-ml solution of 3 mg 0.5% hyperbaric bupivacaine + 25 microg of fentanyl
Trial: 11818036
Drug: 3.5 hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 hour workshop on Evidence Based Medicine (EBM)
Trial: 10367928
Drug: Tamponade treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamponade treatment
Trial: 2076247
Drug: Sucrose-containing snacks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose-containing snacks (chocolate bar, cream-filled cupcakes, cream-filled sandwich cookie, cherry pie, raisins)
Trial: 381221
Drug: Tolmetin 200
RxNorm normalized name: tolmetin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolmetin 200 mg (T 200)
Trial: 381221
Drug: Paracetamol 400
RxNorm normalized name: Hydrocodone bitartrate 5 mg and paracetamol 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 400 mg (P 400)
Trial: 381221
Drug: Tolmetin 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolmetin 150 mg plus Paracetamol 300 mg (T 150 + P 300)
Trial: 381221
Drug: Tolmetin 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolmetin 100 mg plus Paracetamol 400 mg (T 100 + P 400)
Trial: 30404563
Drug: CoQ10 supplementation
RxNorm normalized name: CoQ10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CoQ10 supplementation (300 mg/day)
Trial: 21885886
Drug: Moderate-to-vigorous intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-to-vigorous intensity exercise intervention for 6 months, home-based, telephone-administered
Trial: 11254756
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg/day for 30 days)
Trial: 11254756
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) (600 mg/day for 30 days after a washout period)
Trial: 8200250
Drug: Metronidazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (400 mg thrice daily for seven days)
Trial: 20869152
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium liquid-filled soft gelatin capsule (DPSGC) 25 mg
Trial: 20869152
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium liquid-filled soft gelatin capsule (DPSGC) 50 mg
Trial: 20869152
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium liquid-filled soft gelatin capsule (DPSGC) 100 mg
Trial: 19594501
Drug: Lithium monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium monotherapy (Phase 2)
Trial: 6085377
Drug: Nitrendipine (10‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (10‐40 mg/day)
Trial: 6085377
Drug: Hydralazine (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (50‐200 mg/day)
Trial: 29159774
Drug: Rasagiline transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline transdermal patch (1.25 mg/24 h, 1.25 mg/48 h, 2.5 mg/48 h, 2.5 mg/72 h)
Trial: 29159774
Drug: Rasagiline oral
RxNorm normalized name: rasagiline Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline oral tablet (1 mg)
Trial: 29159774
Drug: Rasagiline transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline transdermal patch (1.25 mg)
Trial: 29159774
Drug: Rasagiline transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline transdermal patch (2.5 mg)
Trial: 29159774
Drug: Rasagiline transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline transdermal patch (1.25-2.5 mg)
Trial: 29159774
Drug: Rasagiline transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline transdermal patch
Trial: 24004349
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplements (800 IU/day)
Trial: 22296077
Drug: GAD‐alum (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GAD‐alum (four doses)
Trial: 22296077
Drug: GAD‐alum (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GAD‐alum (two doses) followed by placebo (two doses)
Trial: 2268811
Drug: Placebo (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (four doses)
Trial: 22296077
Drug: GAD‐alum (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GAD‐alum (any dosage)
Trial: 22296077
Drug: Placebo (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (any dosage)
Trial: 18240797
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel composed of 18% potassium complex, 10% dimethylisosorbide, and 72% aqueous hydroxyethyl cellulose gel applied to the facial skin over painful areas.
Trial: 18240797
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel application as a first-step procedure before definitive diagnosis and treatment.
Trial: 18240797
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel application.
Trial: 15900603
Drug: Imatinib treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib treatment followed by resection of residual disease
Trial: 10519615
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg twice a day) for > or = 5 months
Trial: 8522669
Drug: Enalaprilat 0.015
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat 0.015 mg kg‐1 injected within 5 min to 9 patients
Trial: 1720527
Drug: MODE (at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MODE (at a mean concentration of 774 +/- 229 ng/ml)
Trial: 6758935
Drug: Intravenous tiapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tiapamil (1 mg/kg loading dose followed by 50 micrograms/kg/min for 2 hours)
Trial: 6758935
Drug: Oral tiapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tiapamil (approximately 6 mg/kg)
Trial: 27396815
Drug: Programmed sports
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Programmed sports therapy (PST)
Trial: 24743431
Drug: Fenofibric acid
RxNorm normalized name: Fenofibric Acid
DrugBank: Fenofibric acid (DB13873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibric acid (FA) 135 mg plus atorvastatin
Trial: 24743431
Drug: Fenofibric acid
RxNorm normalized name: Fenofibric Acid
DrugBank: Fenofibric acid (DB13873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibric acid (FA) plus atorvastatin